Sukrit Silas

Sukrit Silas is a highly accomplished individual with an impressive educational background in the field of Molecular Biology, Biochemistry, Chemical and Systems Biology, and Pathology.

He obtained his Bachelor of Arts (AB) in Molecular Biology and Applied Math with Summa cum laude honors from Princeton University, furthering his studies through the Oxford-Princeton Research Exchange program in Biochemistry at the University of Oxford.

Sukrit Silas pursued advanced degrees including a Doctor of Philosophy (PhD) in Chemical and Systems Biology from Stanford University and a Master of Philosophy (MPhil) in Pathology from the University of Cambridge, showcasing his dedication to academic excellence and a multidisciplinary approach to research.

With a strong foundation in academia, Sukrit Silas has also honed his skills in practical research settings through various roles in prestigious organizations. He served as a Damon Runyon Postdoctoral Fellow at the University of California, San Francisco, where he contributed to cutting-edge research in his field.

Additionally, Sukrit Silas leveraged his expertise as the Co-founder and Chief Scientific Officer at BillionToOne, a position that highlights his entrepreneurial spirit and leadership in driving innovative projects. Prior to this, he was recognized as an SPARK Scholar at the SPARK Translational Research and Drug Discovery Program, further solidifying his reputation as a versatile and accomplished professional in the scientific community.